Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Role of IL-16 in CD4(+) T cell-mediated regulation of relapsing multiple sclerosis.
Biological and nonbiological complex drugs for multiple sclerosis in Latin America: regulations and risk management.
Synthesis of fluorinated analogues of sphingosine-1-phosphate antagonists as potential radiotracers for molecular imaging using positron emission tomography.
Multiple sclerosis lesion formation and early evolution revisited: A weekly high-resolution magnetic resonance imaging study.
Seizures and multiple sclerosis in Chinese patients: A clinical and magnetic resonance imaging study.
NLRP3 inflammasome induces chemotactic immune cell migration to the CNS in experimental autoimmune encephalomyelitis.
Assessment of visual disability using visual evoked potentials.
Post-infective transverse myelitis following Streptococcus pneumoniae meningitis with radiological features of acute disseminated encephalomyelitis: a case report.
Insights into the Mechanisms of the Therapeutic Efficacy of Alemtuzumab in Multiple Sclerosis.
Nogo-A: Multiple Roles in CNS Development, Maintenance, and Disease.
Pediatric multiple sclerosis: update in diagnosis and management.
Identifying the Start of Multiple Sclerosis Injury: A Serial DTI Study.
Previous treatment influences fingolimod efficacy in relapsing-remitting multiple sclerosis: results from an observational study.
Bilateral hearing loss as a manifestation of neuromyelitis optica.
Sexual disorders in men with multiple sclerosis: Evaluation and management.
Regional but Not Global Brain Damage Contributes to Fatigue in Multiple Sclerosis.
Acute exacerbation of multiple sclerosis presenting with facial metamorphopsia and palinopsia.
159 Microsurgical descending tractotomy in cases of intractable trigeminal pain syndromes.
Microstructural magnetic resonance imaging of cortical lesions in multiple sclerosis.
FTY720 preserved islet β-cell mass by inhibiting apoptosis and increasing survival of β-cells in db/db mice.
Going Against the Tide - How Encephalitogenic T Cells Breach the Blood-Brain Barrier.
Geomagnetic disturbances may be environmental risk factor for multiple sclerosis: an ecological study of 111 locations in 24 countries.
Meta-analysis reveals an association of PTPN22 C1858T with autoimmune diseases, which depends on the localization of the affected tissue.
Theranostic implications of nanotechnology in multiple sclerosis: a future perspective.
HERVs in neuropathogenesis.
Pages
« first
‹ previous
…
251
252
253
254
255
256
257
258
259
…
next ›
last »